23andMe is low on cash and its stock is worth pennies. The CEO wants another chance

Just three years ago, DNA testing company 23andMe was the golden child of Wall Street and Silicon Valley. Today, the firm is at risk of being delisted from the Nasdaq.

Related Keywords

Stanford ,California ,United States ,Palo Alto High School ,London ,City Of ,United Kingdom ,Anne Wojcicki ,Susan Wojcicki ,Sergey Brin ,Los Angeles ,Kyle Grillot Bloomberg Getty ,Steven Mah ,Justin Sullivan Getty ,Time Magazine ,Nasdaq ,Cnn ,Me Inc ,Google ,Glaxosmithkline ,Wall Street ,Silicon Valley ,Raise Successful People ,Youtube Her ,Big Pharma ,